Breaking News Instant updates and real-time market news.

SHPG

Shire

$172.57

-1.46 (-0.84%)

, TKPYY

Takeda Pharmaceutical

$0.00

(0.00%)

07:19
01/03/19
01/03
07:19
01/03/19
07:19

Shire: Court sanctions scheme of arrangement for Takeda deal

Shire (SHPG) announced that the Royal Court of Jersey has sanctioned the scheme of arrangement pursuant to Article 125 of the Companies Law 1991 by which the recommended cash and share offer made by Takeda Pharmaceutical Company Limited (TKPYY) for the entire issued and to be issued share capital of Shire is being implemented. The Scheme will become effective upon a copy of the Court order being delivered to the registrar of companies in Jersey, which is expected to take place on January 8, 2019. The Scheme will become effective upon a copy of the Court order being delivered to the registrar of companies in Jersey, which is expected to take place on January 8, 2019.

SHPG

Shire

$172.57

-1.46 (-0.84%)

TKPYY

Takeda Pharmaceutical

$0.00

(0.00%)

  • 11

    Jan

  • 28

    Jan

  • 18

    May

SHPG Shire
$172.57

-1.46 (-0.84%)

12/12/18
RHCO
12/12/18
DOWNGRADE
Target $175
RHCO
Hold
Shire downgraded to Hold at SunTrust on Takeda merger
As reported earlier, SunTrust analyst John Boris downgraded Shire (SHPG) to Hold from Buy and lowered his price target to $175 from $190. The analyst cites the changes in FX rates and Takeda (TKPYY) share price in shifting his price target, but expects the deal to close under the same terms on January 8th with no "meaningful hurdles" left to clear until then.
12/17/18
PIPR
12/17/18
NO CHANGE
Target $164
PIPR
Overweight
Shire approval another potential headwind for Allergan, says Piper Jaffray
Piper Jaffray analyst David Amsellem views Shire's (SHPG) FDA approval Friday for its 5-HT4 receptor agonist Motegrity in chronic idiopathic constipation as another potential headwind for Allergan's (AGN) Linzess. The headwind is not necessarily in terms of pressure on volumes, but more in terms of the potential for a more challenging payer environment, Amsellem tells investors in a research note. The analyst remains cautious on Allergan given his concerns regarding the trajectory of the commercial portfolio as well as its pipeline. Amsellem reiterates a Neutral rating on the stock with a $164 price target.
12/18/18
RBCM
12/18/18
NO CHANGE
Target $34
RBCM
Outperform
AMD addition to Nasdaq-100 a 'small near-term positive', says RBC Capital
RBC Capital analyst Mitch Steves notes the addition of AMD (AMD) to the Nasdaq-100 index announced late on Friday, which also contained the inclusion of lululemon (LULU), NetApp (NTAP), United Continental Holdings (UAL), VeriSign (VRSN) and Willis Towers Watson (WLTW) and the subtraction of Express Scripts Holding (ESRX), Hologic (HOLX), Qurate Retail (QRTEA), Shire (SHPG), Seagate Technology (STX) and Vodafone Plc (VOD). The analyst believes that the change - which will become effective before the market open on December 24th - could act as a "small near-term positive" for AMD shares, even though it does not change its fundamentals. Longer term, the analyst keeps his Outperform rating and $34 price target on AMD, but warns that the company is faced with a crypto currency downdraft in the Gaming segment and that he is also cautious on the hyperscale spending trends next year which he estimates in the low single digits. Steves adds that the notable investor debate is also taking place around the AMD server average selling prices, which he sees coming in around $5,400 - the higher end of the more bullish forecasts of $5K-$6K vs. the bears' estimate around $4K.
12/20/18
WBLR
12/20/18
DOWNGRADE
WBLR
Market Perform
Shire downgraded to Market Perform from Outperform at William Blair
William Blair analyst Tim Lugo downgraded Shire (SHPG) to Market Perform to reflect the pending takeover by Takeda Pharmaceutical (TKPYY).
TKPYY Takeda Pharmaceutical
$0.00

(0.00%)

09/07/18
BREN
09/07/18
DOWNGRADE
BREN
Hold
Shire downgraded to Hold from Buy at Berenberg
Berenberg analyst Klara Fernandes downgraded Shire (SHPG) to Hold saying the current valuation offers limited potential upside ahead of the pending takeover by Takeda Pharmaceutical (TKPYY).
11/06/18
RHCO
11/06/18
NO CHANGE
Target $190
RHCO
Buy
Shire price target lowered to $190 from $205 at SunTrust
SunTrust analyst John Boris lowered his price target on Shire (SHPG) to $190 to reflect the impact of the USD appreciation against GBP while also lowering his FY18 EPS view to $15.11 from $15.18. The analyst notes that the investment focus for Shire falls on the November 20th vote by E.U. regulators on its merger with Takeda (TKPYY), adding that the company is on track to secure that approval and for shareholders to vote on the deal in January of next year.

TODAY'S FREE FLY STORIES

CP

Canadian Pacific

$195.71

0.02 (0.01%)

08:21
01/24/19
01/24
08:21
01/24/19
08:21
Recommendations
Canadian Pacific analyst commentary  »

Canadian Pacific price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

08:21
01/24/19
01/24
08:21
01/24/19
08:21
Conference/Events
European Central Bank President Draghi to hold press conference »

ECB President Draghi…

$DJT

DJ Transportation Average

$0.00

(0.00%)

08:20
01/24/19
01/24
08:20
01/24/19
08:20
Technical Analysis
DJ Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$DJU

DJ Utility Average

$0.00

(0.00%)

08:20
01/24/19
01/24
08:20
01/24/19
08:20
Technical Analysis
DJ Utility Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

08:20
01/24/19
01/24
08:20
01/24/19
08:20
Technical Analysis
Dow Jones Industrial Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IYT

iShares Transportation Average

$174.98

-1.01 (-0.57%)

08:20
01/24/19
01/24
08:20
01/24/19
08:20
Technical Analysis
iShares Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLK

Technology Select Sector SPDR

$64.45

0.22 (0.34%)

08:19
01/24/19
01/24
08:19
01/24/19
08:19
Technical Analysis
Technology Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLE

Energy Select Sector SPDR

$61.79

-0.6 (-0.96%)

08:19
01/24/19
01/24
08:19
01/24/19
08:19
Technical Analysis
Energy Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLY

Consumer Discretionary Sector SPDR

$105.40

0.16 (0.15%)

08:19
01/24/19
01/24
08:19
01/24/19
08:19
Technical Analysis
Consumer Discretionary Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLB

S&P Select Materials SPDR

$52.42

-0.34 (-0.64%)

08:19
01/24/19
01/24
08:19
01/24/19
08:19
Technical Analysis
S&P Select Materials SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLNX

Xilinx

$89.55

-0.89 (-0.98%)

08:18
01/24/19
01/24
08:18
01/24/19
08:18
Recommendations
Xilinx analyst commentary  »

Xilinx price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

XLU

Utilities SPDR

$53.79

0.56 (1.05%)

08:18
01/24/19
01/24
08:18
01/24/19
08:18
Technical Analysis
Utilities SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLP

Consumer Staples Sector SPDR

$52.57

0.58 (1.12%)

08:18
01/24/19
01/24
08:18
01/24/19
08:18
Technical Analysis
Consumer Staples Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLV

Health Care Select Sector SPDR

$89.55

0.07 (0.08%)

08:18
01/24/19
01/24
08:18
01/24/19
08:18
Technical Analysis
Health Care Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IWM

iShares Trust Russell 2000 Index Fund

$144.61

-0.36 (-0.25%)

08:17
01/24/19
01/24
08:17
01/24/19
08:17
Technical Analysis
iShares Trust Russell 2000 Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIA

Diamonds Fund ETF

$245.75

1.64 (0.67%)

08:17
01/24/19
01/24
08:17
01/24/19
08:17
Technical Analysis
Diamonds Fund ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HCA

HCA Healthcare

$133.76

0.82 (0.62%)

, UNH

UnitedHealth

$267.12

1.44 (0.54%)

08:17
01/24/19
01/24
08:17
01/24/19
08:17
Recommendations
HCA Healthcare, UnitedHealth, Johnson & Johnson analyst commentary  »

HCA Healthcare elevated…

HCA

HCA Healthcare

$133.76

0.82 (0.62%)

UNH

UnitedHealth

$267.12

1.44 (0.54%)

JNJ

Johnson & Johnson

$128.82

0.06 (0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jan

  • 29

    Jan

  • 18

    Feb

  • 19

    Feb

  • 28

    May

SPY

SPDR S&P 500 ETF Trust

$263.42

0.37 (0.14%)

08:17
01/24/19
01/24
08:17
01/24/19
08:17
Technical Analysis
SPDR S&P 500 ETF Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLF

Financial Select Sector

$25.72

0.01 (0.04%)

08:17
01/24/19
01/24
08:17
01/24/19
08:17
Technical Analysis
Financial Select Sector: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLNX

Xilinx

$89.55

-0.89 (-0.98%)

08:17
01/24/19
01/24
08:17
01/24/19
08:17
Recommendations
Xilinx analyst commentary  »

Xilinx price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

SMH

Market Vectors Semiconductor

$89.82

-0.36 (-0.40%)

08:16
01/24/19
01/24
08:16
01/24/19
08:16
Technical Analysis
Market Vectors Semiconductor: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QQQ

Invesco QQQ Trust

$162.20

0.04 (0.02%)

08:16
01/24/19
01/24
08:16
01/24/19
08:16
Technical Analysis
Invesco QQQ Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$COMP

Nasdaq Composite

$0.00

(0.00%)

08:16
01/24/19
01/24
08:16
01/24/19
08:16
Technical Analysis
Nasdaq Composite: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:16
01/24/19
01/24
08:16
01/24/19
08:16
Conference/Events
JPMorgan to hold a conference »

Thailand Conference will…

NDX

Nasdaq 100 Index

$0.00

(0.00%)

08:16
01/24/19
01/24
08:16
01/24/19
08:16
Technical Analysis
Nasdaq 100 Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.